Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 50, Issue 1, 2000, Pages 65-72

  Abdella, N ^a   Akanji, A O ^a   Mojiminiyi, O A ^a   Al Assoussi, A ^b   Moussa, M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

Albuminuria; Kuwaiti subjects; Sialic acid; Type 2 diabetes

Indexed keywords

ALBUMIN; SIALIC ACID;

ACUTE PHASE RESPONSE; ADULT; AGE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; HUMAN; KUWAIT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; SEX DIFFERENCE; URINARY EXCRETION; VASCULAR DISEASE;

ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CREATININE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; ELECTROCARDIOGRAPHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KUWAIT; LIPIDS; MALE; N-ACETYLNEURAMINIC ACID; OBESITY; RISK FACTORS; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 0033869407     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00144-3     Document Type: Article

References (39)

1. Ng S., Dain J.A. The natural occurrence of sialic acids. Rosenbur A., Schengrund S. Biological Role of Sialic Acid. 1976;59-102 New York, Plenum.
2. Taniuchi K., Chifu K., Hayashi N. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. Kobe J. Med. Sci. 27:1981;91-102.
3. Lindberg G., Eklund G.A., Gulberg B., Rastam L. Serum sialic acid concentration and cardiovascular mortality. Br. Med. J. 302:1991;143-146.
4. El Mugamer I.T., Ali Zayat A.S., Hossain M.M., Pugh R.N.H. Diabetes, obesity and hypertension in urban and rural people of Bedouin origin in the United Arab Emirates. J. Trop. Med. Hyg. 98:1995;407-415.
5. Ahmed A.F., Abdelsalam S.A., Mahmoud M.E., Gadri M.A. A case control study of the incidence of coronary heart disease risk factors in Saudis at Almadina Almounawarah. Saudi Med. J. 14:1993;146-151.
6. Radovanovic Z. Mortality patterns in Kuwait: inferences from death certificate data. Eur. J. Epidemiol. 10:1994;733-736.
7. Kurtz R.A. The leading causes of death in Kuwait. J. Kwt. Med. Assoc. 18:1984;217-233.
8. Abdella N., Al Arouj M., Al Nakhi A., Al Assoussi A., Moussa M. Non-insulin-dependent diabetes in Kuwait: prevalence rates and associated risk factors. Diabetes Res. Clin. Pract. 42:1998;187-196.
9. Pyorala K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab. Rev. 3:1987;463-524.
10. Crook M., Tutt P., Pickup J.C. Elevated serum sialic acid concentration in non-insulin-dependent diabetes and its relationship to blood pressure and retinopathy. Diabetes Care. 16:1993;57-60.
11. Crook M.A., Earle K., Morocutti A., Yip J., Viberti G.C., Pickup J.C. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care. 17:1994;305-310.
12. Rose G.A., Blackburn H., Gillum R.F., Prineas R.J. Cardiovascular survey methods. WHO Monogr. Ser. 56:1982;162-165.
13. Diet, nutrition and the prevention of chronic diseases. Report of a WHO study group. Technical Report Series, No. 797. 1990;WHO, Geneva.
14. Ashwell M., Chinn S., Stalley S., Garrow J.S. Female fat distribution, a photographic and cellularity study. Int. J. Obes. 2:1978;289-302.
15. Cohen J.D., Grimm R.H., Smith W.M. The multiple risk factor intervention trial (MRFIT) VI: intervention on blood pressure. Prev. Med. 10:1981;501-518.
16. Arterial hypertension. Technical Report Series, No. 628. 1978;WHO, Geneva.
17. Blackburn H., Keys A., Simonson E., Rautaharju P., Punsar S. The electrocardiogram in population studies: a classification system. Circulation. 21:1960;1160-1175.
18. Simpson H., Chusney G.D., Crook M.A., Pickup J.C. Serum sialic acid enzymatic assay based on microtiter plates: application for measuring capillary serum sialic acid concentrations. Br. J. Biomed. Sci. 50:1993;164-167.
19. User's Guide. second ed:1986;McGraw-Hill, New York.
20. Mogensen C.E., Chachati A., Christensen C.K. et al. Microalbuminiuria: an early marker of renal involvement in diabetes. Uremia Invest. 9:1985;85-95.
21. Yokoyama H., Jensen J.S., Jensen T., Deckert T. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy. J. Intern. Med. 237:1994;519-523.
22. Taniuchi K., Chifl K., Hayashi N. A new enzymatic method for the determination of sialic acid in serum and its application as a marker of the acute phase reactants. Kobe J. Med. Sci. 27:1981;91-102.
23. Thompson D., Harrison S.P., Evans S.W., Whicher J.T. Insulin modulation of acute-phase protein production in a human hepatoma cell line. Cytokine. 3:1991;619-626.
24. Campos S.P., Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute phase plasma proteins. Mol. Cell. Biol. 12:1992;1789-1797.
25. Islam N., Kazmi F., Chusney G.D., Mattock M.B., Zaini A., Pickup J.C. Serum sialic acid and cardiovascular disease in Malay, Indian and Chinese subjects with NIDDM in Malaysia. Diabetes Res. 32:1997;77-85.
26. Lindberg G., Iso H., Rastam L., Lundblad A., Folsom A.R. Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA. Int. J. Epidemiol. 26:1997;58-63.
27. Mather H.M., Roberts G.A., Kehely A.M., Pasapula C., Chusney G.D., Pickup J.C. Serum sialic acid, a new cardiovascular risk factor, is higher in NIDDM women than men. Diabetologia. 39(suppl. 1):1996;275A.
28. Pickup J.C., Roberts G.A., Kehely A.M., Pasapula C., Chusney G.D., Mather H.M. Higher serum sialic acid in women than in men with NIDDM: possible relevance to increased cardiovascular risk in NIDDM women. Diabetes Care. 20:1997;1496.
29. Pickup J.C., Mattock M.B., Crook M.A., Chusney G.D., Burt D., Fitzgerald A.P. Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care. 18:1995;1100-1103.
30. Chen J.W., Gall M.A., Yokoyama H., Jensen J.S., Deckert M., Parving H.H. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care. 19:1996;130-134.
31. Powrie J.K., Watts G.F., Crook M.A., Ingham J.N., Taub N.A., Shaw K.M. Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus. Diabetic Med. 13:1996;238-243.
32. Haq M., Haq S., Tutt P., Crook M. Serum total acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins. Ann. Clin. Biochem. 30:1993;383-386.
33. Yokoyama H., Jensen J.S., Myrup B., Mathiesen E.R., Ronn B., Deckert T. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. Diabetes Care. 19:1996;435-440.
34. Born G.V., Palinski W. Unusually high concentration of sialic acids on the surface of vascular endothelium. Br. J. Exp. Pathol. 66:1985;543-549.
35. Manduteanul I., Calb M., Lupu C., Simionescu N., Simionescu M. Increased adhesion of human diabetic platelets to cultured vascular endothelial cells. J. Submicrosc. Cytol. Pathol. 24:1992;539-547.
36. Wakabayashi I., Sakamoto K., Yoshimoto S., Masui H. Relation of serum sialic acid to lipid concentrations. Br. Med. J. 305:1992;562-563.
37. Haq S., Haq M., Tutt P., Crook M. Serum sialic acid and acute phase proteins in hypertriglyceridaemic patients showing the Frederickson's type IIb phenotype. Clin. Sci. 85:1993;219-222.
38. McMillan D.E. Increased levels of acute phase proteins in diabetes. Metabolism. 39:1989;1042-1046.
39. Deckert T., Feldt-Rasmussen B., Johnsen B., Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 32:1989;219-226.